Huffman Nichole T, Keightley J Andrew, Chaoying Cui, Midura Ronald J, Lovitch Dinah, Veno Patricia A, Dallas Sarah L, Gorski Jeff P
Bone Biology Program, Department of Oral Biology, School of Dentistry, University of Missouri, Kansas City, Missouri 64108, USA.
J Biol Chem. 2007 Sep 7;282(36):26002-13. doi: 10.1074/jbc.M701332200. Epub 2007 Jul 5.
Mineral crystal nucleation in UMR 106-01 osteoblastic cultures occurs within 15-25-microm extracellular vesicle-containing biomineralization foci (BMF) structures. We show here that BAG-75 and BSP, biomarkers for these foci, are specifically enriched in laser capture microscope-isolated mineralized BMF as compared with the total cell layer. Unexpectedly, fragments of each protein (45-50 kDa in apparent size) were also enriched within captured BMF. When a series of inhibitors against different protease classes were screened, serine protease inhibitor 4-(2-aminoethyl)benzenesulfonylfluoride HCl (AEBSF) was the only one that completely blocked mineral nucleation within BMF in UMR cultures. AEBSF appeared to act on an osteoblast-derived protease at a late differentiation stage in this culture model just prior to mineral deposition. Similarly, mineralization of bone nodules in primary mouse calvarial osteoblastic cultures was completely blocked by AEBSF. Cleavage of BAG-75 and BSP was also inhibited at the minimum dosage of AEBSF sufficient to completely block mineralization of BMF. Two-dimensional SDS-PAGE comparisons of AEBSF-treated and untreated UMR cultures showed that fragmentation/activation of a limited number of other mineralization-related proteins was also blocked. Taken together, our results indicate for the first time that cleavage of BAG-75 and BSP by an AEBSF-sensitive, osteoblast-derived serine protease is associated with mineral crystal nucleation in BMF and suggest that such proteolytic events are a permissive step for mineralization to proceed.
UMR 106-01成骨细胞培养中的矿物晶体成核发生在含有15 - 25微米细胞外囊泡的生物矿化灶(BMF)结构内。我们在此表明,作为这些病灶生物标志物的BAG-75和骨唾液蛋白(BSP),与整个细胞层相比,在激光捕获显微镜分离的矿化BMF中特异性富集。出乎意料的是,每种蛋白质的片段(表观大小为45 - 50 kDa)在捕获的BMF中也有富集。当筛选一系列针对不同蛋白酶类别的抑制剂时,丝氨酸蛋白酶抑制剂4 -(2 - 氨基乙基)苯磺酰氟盐酸盐(AEBSF)是唯一能完全阻断UMR培养物中BMF内矿物成核的抑制剂。在这个培养模型中,AEBSF似乎在矿化沉积前的成骨细胞分化后期作用于一种成骨细胞衍生的蛋白酶。同样,AEBSF完全阻断了原代小鼠颅骨成骨细胞培养中骨结节的矿化。在足以完全阻断BMF矿化的最低剂量AEBSF下,BAG-75和BSP的切割也受到抑制。对经AEBSF处理和未处理的UMR培养物进行的二维SDS-PAGE比较表明,有限数量的其他矿化相关蛋白的片段化/激活也被阻断。综上所述,我们的结果首次表明,AEBSF敏感的、成骨细胞衍生的丝氨酸蛋白酶对BAG-75和BSP的切割与BMF中的矿物晶体成核有关,并表明这种蛋白水解事件是矿化进行的一个允许步骤。